Alongside their weight-loss effects by inhibiting appetite, GLP-1 receptor agonists also lead to reductions in lean body mass, including muscle and supportive fat pads, which can result in unintended effects: hollowing of the face, softening of the jawline, loss of core strength, or laxity in the neck and lower face
Specific bacterial metabolites, particularly short-chain fatty acids like butyrate, bind to receptors on L-cells (specifically GPR41 and GPR43) and stimulate GLP-1 release
Subjective arousal effects typically begin 6090 minutes post-injection, coinciding with peak plasma concentration and central melanocortin receptor occupancy
Start with the lowest prescribed dose
This article aims to review a broad spectrum of tongue diseases based on the authors clinical experiences
Its important to get enough lean protein and water throughout the day